Peggy Hawkins

Peggy Hawkins has a strong background in business development within the biotechnology industry. Peggy held various roles at Exelixis, starting as an Executive Director of Business Development in December 2019. In March 2021, they were promoted to Vice President of Business Development. Exelixis is a successful oncology-focused biotechnology company that develops and commercializes medicines for difficult-to-treat cancers. Prior to joining Exelixis, Peggy served as a Licensing Director of Business Development at Amgen from August 2017 to December 2019.

Peggy Hawkins earned a Bachelor of Science (BS) degree from the University of Michigan. Peggy subsequently pursued a Doctor of Law (JD) degree at the University of Washington School of Law.